Impel Pharmaceuticals Inc (IMPL) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Impel Pharmaceuticals Inc   (NASDAQ: IMPL)
 

Impel Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Impel Pharmaceuticals Inc inventory turnover ratio, the Impel Pharmaceuticals Inc 's ability to sell and replace its inventory in the third quarter 2023, sequentially increased to 1.25 in the third quarter 2023, a new company high. Average inventory processing period, for the Impel Pharmaceuticals Inc in Sep 30 2023 quarter, has decreased to 292 days, compare to 326 days, in the Jun 30 2023 quarter.

Within Healthcare sector 311 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 1415, from total ranking in the second quarter 2023 at 1607.

IMPL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Impel Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMPL Inventory Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Inventory Growth -20.39 % 0.81 % 45.82 % 198.41 % 456.98 %
Y / Y Cost of Sales Growth 32.63 % 72.71 % 121.2 % 402.72 % 503.2 %
Inventory Turnover Ratio (TTM) 1.25 1.12 0.97 0.88 0.79
IMPL's Total Ranking # 1415 # 1607 # 1628 # 1982 # 1855
Average inventory processing period 291 325 377 414 462
Seq. Inventory Growth -1.73 % -12.84 % -4.9 % -2.26 % 24.43 %
Seq. Cost of Sales Growth -33.33 % 31.29 % 3.07 % 47.02 % -13.18 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 97
Healthcare Sector # 312
Overall Market # 1415

Inventory Turnover Ratio Statistics
High Average Low
1.25 0.97 0.79
(Sep 30 2023)   (Sep 30 2022)



IMPL Company Profile >> Back to IMPL Efficiency Comparisons >> Compare IMPL Inventory Turnover Ratio to its Competitors

Financial Statements
Impel Pharmaceuticals Inc 's Inventories $ 7 Millions Visit IMPL's Balance sheet
Impel Pharmaceuticals Inc 's Cost of Revenues TTM $ 10 Millions Visit IMPL's Income Statement
What are IMPL's Sales? Visit IMPL's Sales by Segment

Other Inventory Turnover Ratios
Impel Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IMPL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IMPL's Competitors
Inventory Turnover Ratio for IMPL's Suppliers
Inventory Turnover Ratio for IMPL's Customers

You may also want to know
IMPL's Sales Growth Rates IMPL's Pe Price to earnings ratio IMPL's Receivables Turnover Ratio IMPL's Stock Quote
IMPL's Net Income Growth Rates IMPL's Ps Price to Sales ratio IMPL's Sales per Employee IMPL's Asset Turnover Ratio
IMPL's Net Margin IMPL's Pb Price to Book ratio IMPL's Financial Strength Ratios IMPL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Envista Holdings Corporation  3.75 $ 1,110.900  Millions$ 296  Millions
Idexx Laboratories Inc  3.72 $ 1,440.970  Millions$ 387  Millions
T2 Biosystems Inc   3.70 $ 16.519  Millions$ 4  Millions
Align Technology inc   3.66 $ 1,151.307  Millions$ 315  Millions
Tactile Systems Technology Inc   3.64 $ 79.181  Millions$ 22  Millions
Gilead Sciences Inc   3.64 $ 5,804.000  Millions$ 1,595  Millions
Invo Fertility Inc   3.62 $ 0.968  Millions$ 0  Millions
Aurinia Pharmaceuticals Inc   3.61 $ 10.115  Millions$ 3  Millions
Cadre Holdings inc   3.61 $ 281.247  Millions$ 78  Millions
Endo International Plc  3.58 $ 991.146  Millions$ 277  Millions
Pressure Biosciences Inc   3.57 $ 2.116  Millions$ 1  Millions
3m Company  3.50 $ 18,384.000  Millions$ 5,256  Millions
Baxter International Inc   3.48 $ 9,913.000  Millions$ 2,853  Millions
Orasure Technologies Inc  3.47 $ 265.637  Millions$ 76  Millions
Maravai Lifesciences Holdings Inc   3.43 $ 166.888  Millions$ 49  Millions
Mimedx Group Inc   3.41 $ 54.371  Millions$ 16  Millions
Lftd Partners Inc   3.40 $ 28.850  Millions$ 8  Millions
Caredx Inc   3.37 $ 62.494  Millions$ 19  Millions
Nexgel Inc   3.34 $ 3.040  Millions$ 1  Millions
Aquestive Therapeutics Inc   3.33 $ 21.457  Millions$ 6  Millions
Sunshine Biopharma Inc   3.32 $ 13.090  Millions$ 4  Millions
Neogen Corporation  3.30 $ 457.921  Millions$ 139  Millions
Enzo Biochem Inc  3.27 $ 38.084  Millions$ 12  Millions
Revvity Inc  3.26 $ 1,748.575  Millions$ 536  Millions
Dynatronics Corporation  3.24 $ 28.117  Millions$ 9  Millions
Becton Dickinson And Company  3.17 $ 11,202.000  Millions$ 3,530  Millions
Myomo Inc   3.15 $ 4.553  Millions$ 1  Millions
Electromed Inc   3.14 $ 12.047  Millions$ 4  Millions
Agilent Technologies inc   3.12 $ 3,368.000  Millions$ 1,079  Millions
Prestige Consumer Healthcare Inc   3.11 $ 507.227  Millions$ 163  Millions

Date modified: 2026-08-29T17:43:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.